These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23134618)

  • 21. Context-specific protein network miner--an online system for exploring context-specific protein interaction networks from the literature.
    Chowdhary R; Tan SL; Zhang J; Karnik S; Bajic VB; Liu JS
    PLoS One; 2012; 7(4):e34480. PubMed ID: 22493694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BRCA-Monet: a breast cancer specific drug treatment mode-of-action network for treatment effective prediction using large scale microarray database.
    Ma C; Chen HI; Flores M; Huang Y; Chen Y
    BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S5. PubMed ID: 24564956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of novel biomarkers and small molecule drugs in human colorectal cancer by microarray and bioinformatics analysis.
    Chen J; Wang Z; Shen X; Cui X; Guo Y
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00713. PubMed ID: 31087508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ProteoLens: a visual analytic tool for multi-scale database-driven biological network data mining.
    Huan T; Sivachenko AY; Harrison SH; Chen JY
    BMC Bioinformatics; 2008 Aug; 9 Suppl 9(Suppl 9):S5. PubMed ID: 18793469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toward developing a metastatic breast cancer treatment strategy that incorporates history of response to previous treatments.
    Olow AK; Veer LV'; Wolf DM
    BMC Cancer; 2021 Mar; 21(1):212. PubMed ID: 33648460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data.
    Wang YW; Zhang W; Ma R
    Oncol Rep; 2018 Mar; 39(3):1003-1010. PubMed ID: 29328395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A network based approach to drug repositioning identifies plausible candidates for breast cancer and prostate cancer.
    Chen HR; Sherr DH; Hu Z; DeLisi C
    BMC Med Genomics; 2016 Jul; 9(1):51. PubMed ID: 27475327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An integrated meta-analysis approach to identifying medications with potential to alter breast cancer risk through connectivity mapping.
    Thillaiyampalam G; Liberante F; Murray L; Cardwell C; Mills K; Zhang SD
    BMC Bioinformatics; 2017 Dec; 18(1):581. PubMed ID: 29268695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systems pharmacology strategies for drug discovery and combination with applications to cardiovascular diseases.
    Li P; Chen J; Wang J; Zhou W; Wang X; Li B; Tao W; Wang W; Wang Y; Yang L
    J Ethnopharmacol; 2014; 151(1):93-107. PubMed ID: 23850710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of the mechanisms of Xiaoai Jiedu Recipe in the treatment of breast cancer: A comprehensive approach study with experimental validation.
    Li Y; Li R; Zeng Z; Li S; Luo S; Wu J; Zhou C; Xu D
    J Ethnopharmacol; 2020 Apr; 252():112603. PubMed ID: 31981747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting breast cancer drug response using a multiple-layer cell line drug response network model.
    Huang S; Hu P; Lakowski TM
    BMC Cancer; 2021 May; 21(1):648. PubMed ID: 34059012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. cMapper: gene-centric connectivity mapper for EBI-RDF platform.
    Shoaib M; Ansari AA; Ahn SM
    Bioinformatics; 2017 Jan; 33(2):266-271. PubMed ID: 27667790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening of Prognostic Factors in Early-Onset Breast Cancer.
    Yu Z; He Q; Xu G
    Technol Cancer Res Treat; 2020; 19():1533033819893670. PubMed ID: 32028860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Connectivity mapping using a combined gene signature from multiple colorectal cancer datasets identified candidate drugs including existing chemotherapies.
    Wen Q; O'Reilly P; Dunne PD; Lawler M; Van Schaeybroeck S; Salto-Tellez M; Hamilton P; Zhang SD
    BMC Syst Biol; 2015; 9 Suppl 5(Suppl 5):S4. PubMed ID: 26356760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ResMarkerDB: a database of biomarkers of response to antibody therapy in breast and colorectal cancer.
    Pérez-Granado J; Piñero J; Furlong LI
    Database (Oxford); 2019 Jan; 2019():. PubMed ID: 31169290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantifying differential gene connectivity between disease states for objective identification of disease-relevant genes.
    Chu JH; Lazarus R; Carey VJ; Raby BA
    BMC Syst Biol; 2011 May; 5():89. PubMed ID: 21627793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MOSAIC: a chemical-genetic interaction data repository and web resource for exploring chemical modes of action.
    Nelson J; Simpkins SW; Safizadeh H; Li SC; Piotrowski JS; Hirano H; Yashiroda Y; Osada H; Yoshida M; Boone C; Myers CL
    Bioinformatics; 2018 Apr; 34(7):1251-1252. PubMed ID: 29206899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of the Anti-Tumor Mechanism of Calycosin Against Colorectal Cancer by Using System Pharmacology Approach.
    Huang C; Li R; Shi W; Huang Z
    Med Sci Monit; 2019 Jul; 25():5589-5593. PubMed ID: 31352466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting Adverse Drug Effects from Literature- and Database-Mined Assertions.
    La MK; Sedykh A; Fourches D; Muratov E; Tropsha A
    Drug Saf; 2018 Nov; 41(11):1059-1072. PubMed ID: 29876834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.